ENT Institute and Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, People's Republic of China.
Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.
J Transl Med. 2023 Mar 3;21(1):167. doi: 10.1186/s12967-023-03910-4.
Tumor-associated macrophages (TAMs) are major component in the tumor microenvironment (TME) and play regulatory role in tumor progression. We aimed to investigate the infiltration and prognostic value of TAMs in laryngeal squamous cell carcinoma (LSCC) and to reveal the underlying mechanism of TAM subgroups in tumorigenesis.
Hematoxylin and eosin (HE) staining were performed to define the tumor nest and stroma of LSCC tissue microarrays. CD206 + /CD163 + and iNOS + TAM infiltrating profiles were obtained and analyzed through double-labeling immunofluorescence and immunohistochemical staining. The recurrence-free (RFS) and overall survival (OS) curves based on the infiltration of TAMs were plotted using the Kaplan-Meier method. Infiltration of macrophages, T lymphocytes and their corresponding subgroups were analyzed in fresh LSCC tissue samples by flow cytometry.
We found that CD206 rather than CD163 M2-like TAMs were the most enriched population in the TME of human LSCC. CD206 macrophages localized mostly in the tumor stroma (TS) rather than the tumor nest (TN) region. In contrast, relatively low infiltration of iNOS M1-like TAMs were found in the TS and almost none in the TN region. High level of TS CD206 TAM infiltration correlated with poor prognosis. Interestingly, we identified a HLA-DR CD206 macrophage subgroup that was significantly associated with the tumor-infiltrating CD4 T lymphocytes and showed different surface costimulatory molecule expression than that of the HLA-DR-CD206 subgroup. Taken together, our results indicate that HLA-DR-CD206 is a highly activated subgroup of CD206 + TAMs that may interact with CD4 + T cells through MHC-II axis and promote tumorigenesis.
肿瘤相关巨噬细胞(TAMs)是肿瘤微环境(TME)的主要组成部分,在肿瘤进展中发挥调节作用。我们旨在研究 TAMs 在喉鳞状细胞癌(LSCC)中的浸润和预后价值,并揭示 TAM 亚群在肿瘤发生中的潜在机制。
通过苏木精和伊红(HE)染色定义 LSCC 组织微阵列的肿瘤巢和基质。通过双标记免疫荧光和免疫组织化学染色获得并分析 CD206+ / CD163+和 iNOS+ TAM 浸润图谱。根据 TAMs 的浸润情况绘制无复发生存(RFS)和总生存(OS)曲线,采用 Kaplan-Meier 法。通过流式细胞术分析新鲜 LSCC 组织样本中巨噬细胞、T 淋巴细胞及其相应亚群的浸润情况。
我们发现 CD206 而非 CD163 M2 样 TAMs 是人类 LSCC TME 中最丰富的群体。CD206 巨噬细胞主要位于肿瘤基质(TS)而不是肿瘤巢(TN)区域。相比之下,TS 中 iNOS M1 样 TAMs 的浸润程度较低,而在 TN 区域几乎没有。高水平的 TS CD206 TAM 浸润与预后不良相关。有趣的是,我们鉴定出一个 HLA-DR CD206 巨噬细胞亚群,该亚群与肿瘤浸润性 CD4 T 淋巴细胞显著相关,并表现出与 HLA-DR-CD206 亚群不同的表面共刺激分子表达。总之,我们的研究结果表明,HLA-DR-CD206 是 CD206+TAMs 的一个高度激活亚群,它可能通过 MHC-II 轴与 CD4+T 细胞相互作用并促进肿瘤发生。